Virax Biolabs Group Limit... (VRAX)

1.65

-0.06 (-3.51%)

At close: Feb 28, 2025, 3:59 PM

1.67

1.21%

After-hours: Feb 28, 2025, 04:00 PM EST

Virax Biolabs Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-6.74M	-5.46M	-1.71M	-650.98K	-739.46K
Depreciation & Amortization	103.1K	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.01M	1.73M	290.36K	n/a	n/a
Other Working Capital	-269.56K	-237.23K	2.19K	0.00	n/a
Other Non-Cash Items	497.06K	-260.6K	-32.07K	1.19K	91.67K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.12M	-216.28K	644.39K	59.61K	-96.82K
Operating Cash Flow	-6.25M	-4.18M	-809.07K	-590.19K	-744.61K
Capital Expenditures	-1.16M	-178.4K	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-211.95K	-178.4K	n/a	n/a	n/a
Investing Cash Flow	-1.16M	-178.4K	n/a	n/a	n/a
Debt Repayment	-206.27K	146.25K	100K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.85M	-111.64K	193.59K	585.2K	704.64K
Financial Cash Flow	1.65M	13.69M	813.21K	585.2K	704.64K
Net Cash Flow	-5.76M	9.33M	4.13K	-4.99K	-39.97K
Free Cash Flow	-7.41M	-4.36M	-809.07K	-590.19K	-744.61K